Advertisement

International Journal of Clinical Pharmacy

, Volume 40, Issue 2, pp 325–334 | Cite as

The scope of drug-related problems in the home care setting

  • Carla Meyer-Massetti
  • Christoph R. Meier
  • B. Joseph Guglielmo
Review Article

Abstract

Introduction While drug-related problems (DRPs) in the inpatient setting are well known, the scope of these problems in home care has not been critically evaluated. Aim of the Review Our primary objective was to evaluate the incidence and demographics of DRPs in home care. Our specific aims were to characterize the rate of potentially inappropriate medications (PIMs), medication errors (MEs) and adverse drug events (ADEs) and to identify risk factors which contribute to DRPs in the home care setting. Methods Pubmed, Embase and CiNAHL databases were systematically searched from January 2000 to December 2016 for all publications which quantitatively characterized DRPs in the home care setting. Results The most commonly reported DRPs characterized in studies were PIMs (n = 16), MEs (n = 4) and the ME-subcategory medication-related discrepancies (n = 7). The frequency of PIMs ranged from 19.8 to 48.4%; up to 26% PIMs were considered severe. Polypharmacy (≥ 9 drugs) and increasing age were the most common risk factors for DRPs. Insufficient interdisciplinary teamwork and inconsistent performance of medication reviews were also risks factors for DRPs. Patients and/or caregivers were responsible for 42.3% of DRPs. Discussion Compared with acute inpatient care, DRPs are more frequently reported in home care. The rate of DRPs varies depending upon the reference used to define the problem. Conclusion Transfer of complete medical records and the use of an interdisciplinary team have the potential to reduce DRPs, including MEs, specifically when integrating a pharmacist providing regular medication review. Importantly, patients and informal caregivers must be significant partners with this interdisciplinary team.

Keywords

Drug-related problems Home care Interprofessional collaboration Medication safety Seamless care Transition of care 

Notes

Acknowledgements

The authors would like to thank Heidrun Janka, Medical Library, University of Basel/Switzerland for her guidance in systematically navigating the medication safety literature.

Funding

Part of this work was funded by the non-for-profit Home Care Organization Spitex Stadt Luzern/Switzerland, the Spitex Association of the Canton of Lucerne/Switzerland, the Department of Health of the Canton of Lucerne/Switzerland, and the LOA IV foundation of the Swiss Society of Pharmacists and the Swiss health insurance companies.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Supplementary material

11096_2017_581_MOESM1_ESM.pdf (152 kb)
Supplementary material 1 (PDF 152 kb)

References

  1. 1.
    Landrigan CP, Parry GJ, Bones CB, Hackbarth AD, Goldmann DA, Sharek PJ. Temporal trends in rates of patient harm resulting from medical care. NEnglJ Med. 2010;363(22):2124–34.CrossRefGoogle Scholar
  2. 2.
    Hofer-Dueckelmann C, Prinz E, Beindl W, Szymanski J, Fellhofer G, Pichler M, et al. Adverse drug reactions (ADRs) associated with hospital admissions–elderly female patients are at highest risk. Int J Clin Pharmacol Ther. 2011;49(10):577–86.CrossRefPubMedGoogle Scholar
  3. 3.
    Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30(5):379–407.CrossRefPubMedGoogle Scholar
  4. 4.
    Salvi F, Marchetti A, D’Angelo F, Boemi M, Lattanzio F, Cherubini A. Adverse drug events as a cause of hospitalization in older adults. Drug Saf. 2012;35(Suppl 1):29–45.CrossRefPubMedGoogle Scholar
  5. 5.
    Meyer-Massetti C, Kaiser E, Hedinger-Grogg B, Luterbacher S, Hersberger K. Medikationssicherheit im home-care-bereich: identifikation von kritischen prozessschritten. Pflege. 2012;25(4):261–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Ellenbecker CH, Frazier SC, Verney S. Nurses’ observations and experiences of problems and adverse effects of medication management in home care. Geriatr Nurs. 2004;25(3):164–70.CrossRefPubMedGoogle Scholar
  7. 7.
    Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Heal Inf Libr J. 2009;26(2):91–108.CrossRefGoogle Scholar
  8. 8.
    Hepler CD, Segal R. Preventing medication errors and improving drug therapy outcomes, a management systems approach. Boca Raton: CRC Press; 2003.CrossRefGoogle Scholar
  9. 9.
    Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157(14):1531–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151(9):1825–32.CrossRefPubMedGoogle Scholar
  11. 11.
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the beers criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163(22):2716.CrossRefPubMedGoogle Scholar
  12. 12.
    van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38(5):859–67.CrossRefPubMedGoogle Scholar
  13. 13.
    Akram F, Huggan PJ, Lim V, Huang Y, Siddiqui FJ, Assam PN, et al. Medication discrepancies and associated risk factors identified among elderly patients discharged from a tertiary hospital in Singapore. Singapore Med J. 2015;56(7):379–84.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Pippins JR, Gandhi TK, Hamann C, Ndumele CD, Labonville SA, Diedrichsen EK, et al. Classifying and predicting errors of inpatient medication reconciliation. J Gen Intern Med. 2008;23(9):1414–22.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Onda M, Imai H, Takada Y, Fujii S, Shono T, Nanaumi Y. Identification and prevalence of adverse drug events caused by potentially inappropriate medication in homebound elderly patients: a retrospective study using a nationwide survey in Japan. BMJ Open. 2015;5(8):e007581.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Johnson KG. Adverse events among winnipeg home care clients. Heal Q. 2006 9: 127–34.Google Scholar
  17. 17.
    Hu SH, Capezuti E, Foust JB, Boltz MP, Kim H. Medication discrepancy and potentially inappropriate medication in older Chinese-American home-care patients after hospital discharge. Am J Geriatr Pharmacother. 2012;10(5):284–95.CrossRefPubMedGoogle Scholar
  18. 18.
    Halvorsen KH, Granas AG, Engeland A, Ruths S. Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs. Pharmacoepidemiol Drug Saf. 2012;21(9):929–36.CrossRefPubMedGoogle Scholar
  19. 19.
    Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother. 2006;4(2):134–43.CrossRefPubMedGoogle Scholar
  20. 20.
    Hamano J, Ozone S, Tokuda Y. A comparison of estimated drug costs of potentially inappropriate medications between older patients receiving nurse home visit services and patients receiving pharmacist home visit services: a cross-sectional and propensity score analysis. BMC Heal Serv Res. 2015;15:73.CrossRefGoogle Scholar
  21. 21.
    Bao Y, Shao H, Bishop TF, Schackman BR, Bruce ML. Inappropriate medication in a national sample of US elderly patients receiving home health care. J Gen Intern Med. 2012;27(3):304–10.CrossRefPubMedGoogle Scholar
  22. 22.
    Alhmoud E, Khalifa S, Bahi AA. Prevalence and predictors of potentially inappropriate medications among home care elderly patients in Qatar. Int J Clin Pharm. 2015;37(5):815–21.CrossRefPubMedGoogle Scholar
  23. 23.
    Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348–58.CrossRefPubMedGoogle Scholar
  24. 24.
    Tsao CH, Tsai CF, Lee YT, Weng MC, Lee HC, Lin DB, et al. Drug prescribing in the elderly receiving home care. Am J Med Sci. 2016;352(2):134–40.CrossRefPubMedGoogle Scholar
  25. 25.
    Chang CB, Lai HY, Yang SY, Wu RS, Liu HC, Hsu HY, et al. Patient- and clinic visit-related factors associated with potentially inappropriate medication use among older home healthcare service recipients. PLoS ONE. 2014;9(4):e94350.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Elliott RA, Lee CY, Beanland C, Vakil K, Goeman D. Medicines management, medication errors and adverse medication events in older people referred to a community nursing service: a retrospective observational study. Drugs Real World Outcomes. 2016;3:13–24.CrossRefPubMedCentralGoogle Scholar
  27. 27.
    Schwarze T, Schneeberger M. Medication standard. Error management in Spitex. Krankenpfl Soins Infirm. 2008;101(9):26–7.PubMedGoogle Scholar
  28. 28.
    Meredith S, Feldman PH, Frey D, Hall K, Arnold K, Brown NJ, et al. Possible medication errors in home healthcare patients. J Am Geriatr Soc. 2001;49(6):719–24.CrossRefPubMedGoogle Scholar
  29. 29.
    Tiihonen M, Nykanen I, Ahonen R, Hartikainen S. Discrepancies between in-home interviews and electronic medical records on regularly used drugs among home care clients. Pharmacoepidemiol Drug Saf. 2016;25(1):100–5.CrossRefPubMedGoogle Scholar
  30. 30.
    Lancaster R, Marek KD, Bub LD, Stetzer F. Medication regimens of frail older adults after discharge from home healthcare. Home Heal Nurse. 2014;32(9):536–42.CrossRefGoogle Scholar
  31. 31.
    Hale J, Neal EB, Myers A, Wright KH, Triplett J, Brown LB, et al. Medication discrepancies and associated risk factors identified in home health patients. Home Heal Now. 2015;33(9):493–9.Google Scholar
  32. 32.
    Setter SM, Corbett CF, Neumiller JJ, Gates BJ, Sclar DA, Sonnett TE. Effectiveness of a pharmacist-nurse intervention on resolving medication discrepancies for patients transitioning from hospital to home health care. Am J Health Syst Pharm. 2009;66(22):2027–31.CrossRefPubMedGoogle Scholar
  33. 33.
    Ermer M, Harder S. Medication review of community-dwelling seniors using intensified home-care service. Int J Clin Pharmacol Ther. 2011;49(3):179–84.CrossRefPubMedGoogle Scholar
  34. 34.
    Classen S, MStat WM, Walsh K, Mann W. The relationship of classes of commonly prescribed medications to functional status and quality of life for frail home-based older adults. Phys Occup Ther Geriatr [Internet]. 2006 Jan 28 [cited 2017 Jan 1];24(1):25–44. Available from: http://www.tandfonline.com/doi/full/10.1080/J148v24n01_02.
  35. 35.
    Triller DM, Clause SL, Briceland LL, Hamilton RA. Resolution of drug-related problems in home care patients through a pharmacy referral service. Am J Heal Syst Pharm. 2003;60(9):905–10.Google Scholar
  36. 36.
    Zillich AJ, Snyder ME, Frail CK, Lewis JL, Deshotels D, Dunham P, et al. A randomized, controlled pragmatic trial of telephonic medication therapy management to reduce hospitalization in home health patients. Health Serv Res. 2014;49(5):1537–54.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Sears N, Baker GR, Barnsley J, Shortt S. The incidence of adverse events among home care patients. Int J Qual Heal Care. 2013;25(1):16–28.CrossRefGoogle Scholar
  38. 38.
    Doran D, Hirdes JP, Blais R, Baker GR, Poss JW, Li X, et al. Adverse events associated with hospitalization or detected through the RAI-HC assessment among Canadian home care clients. Heal Policy. 2013;9(1):76–88.Google Scholar
  39. 39.
    Runganga M, Peel NM, Hubbard RE. Multiple medication use in older patients in post-acute transitional care: a prospective cohort study. Clin Interv Aging. 2014;9:1453–62.PubMedPubMedCentralGoogle Scholar
  40. 40.
    Alkema GE, Enguidanos SM, Wilber KH, Trufasiu M, Simmons WJ, Frey D. The role of consultant pharmacists in reducing medication problems among older adults receiving Medicaid waiver services. Consult Pharm. 2009;24(2):121–33.CrossRefPubMedGoogle Scholar
  41. 41.
    Dilks S, Emblin K, Nash I, Jefferies S. Pharmacy at home: service for frail older patients demonstrates medicines risk reduction and admission avoidance. Clin Pharm. 2016;8(7).  https://doi.org/10.1211/CP.2016.20201303.
  42. 42.
    Berti G, Bacchetto FM, Lebboroni M, Faronato PP, Alberti G. Analysis of patient prescriptions about home assistance integrated. G Ital di Farm Clin. 2007;21(2):82–8.Google Scholar
  43. 43.
    LeBlanc RG, Choi J. Optimizing medication safety in the home. Home Healthc Now. 2015;33(6):313–9.PubMedGoogle Scholar
  44. 44.
    Alkema GE, Wilber KH, Simmons WJ, Enguidanos SM, Frey D. Prevalence of potential medication problems among dually eligible older adults in Medicaid waiver services. Ann Pharmacother. 2007;41(12):1971–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Brown EL, Raue PJ, Mlodzianowski AE, Meyers BS, Greenberg RL, Bruce ML. Transition to home care: quality of mental health, pharmacy, and medical history information. Int J Psychiatry Med. 2006;36(3):339–49.CrossRefPubMedGoogle Scholar
  46. 46.
    Brahmbhatt M, Palla K, Kossifologos A, Mitchell D, Lee T. Appropriateness of medication prescribing using the STOPP/START criteria in veterans receiving home-based primary care. Consult Pharm. 2013;28(6):361–9.CrossRefPubMedGoogle Scholar
  47. 47.
    Mager DD, Madigan EA. Medication use among older adults in a home care setting. Home Healthc Nurse [Internet]. 2010;28(1):14–21.CrossRefGoogle Scholar
  48. 48.
    Aufseeser-Weiss MR, Ondeck DA. Medication use risk management: hospital meets home care. J Nurs Care Qual. 2001;15(2):50–7.CrossRefPubMedGoogle Scholar
  49. 49.
    Meyer-Massetti C, Cheng CM, Schwappach DLB, Paulsen L, Ide B, Meier CR, et al. Systematic review of medication safety assessment methods. Am J Heal Pharm. 2011;68(3):227–40.CrossRefGoogle Scholar
  50. 50.
    Kaufmann CP, Stampfli D, Hersberger KE, Lampert ML. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5(3):e006376.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Fortinsky RH, Madigan EA, Sheehan TJ, Tullai-McGuinness S, Kleppinger A. Risk factors for hospitalization in a national sample of medicare home health care patients. J Appl Gerontol. 2014;33(4):474–93.CrossRefPubMedGoogle Scholar
  52. 52.
    Roten I, Marty S, Beney J. Electronic screening of medical records to detect inpatients at risk of drug-related problems. Pharm World Sci. 2009;1573–739X.Google Scholar
  53. 53.
    Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27(4):481–93.CrossRefPubMedGoogle Scholar
  54. 54.
    Vink J, Morton D, Ferreri S. Pharmacist identification of medication-related problems in the home care setting. Consult Pharm. 2011;26(7):477–84.CrossRefPubMedGoogle Scholar
  55. 55.
    MacAulay S, Saulnier L, Gould O. Provision of clinical pharmacy services in the home to patients recently discharged from hospital: a pilot project. Can J Hosp Pharm. 2008.  https://doi.org/10.4212/cjhp.v61i2.26.
  56. 56.
    Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–80.CrossRefPubMedGoogle Scholar
  57. 57.
    Ward KT, Bates-Jensen B, Eslami MS, Whiteman E, Dattoma L, Friedman JL, et al. Addressing delays in medication administration for patients transferred from the hospital to the nursing home: a pilot quality improvement project. Am J Geriatr Pharmacother [Internet]. 2008;6(4):205–11.CrossRefGoogle Scholar
  58. 58.
    Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004;2(4):257–64.CrossRefPubMedGoogle Scholar
  59. 59.
    Ensing HT, Koster ES, van Berkel PI, van Dooren AA, Bouvy ML. Problems with continuity of care identified by community pharmacists post-discharge. J Clin Pharm Ther 2016.Google Scholar
  60. 60.
    Dierich MT, Mueller C, Westra BL. Medication regimens in older home care patients. J Gerontol Nurs. 2011;37(12):45–55.CrossRefPubMedGoogle Scholar
  61. 61.
    Hamano J, Tokuda Y. Inappropriate prescribing among elderly home care patients in Japan: prevalence and risk factors. J Prim Care Community Heal. 2014;5(2):90–6.CrossRefGoogle Scholar
  62. 62.
    Hu SH, Foust JB, Boltz M, Capezuti E. Subtypes of potentially inappropriate medications in older Chinese-Americans during care transitions: cross sectional retrospective study. Int J Nurs Stud. 2014;51(9):1221–9.CrossRefPubMedGoogle Scholar
  63. 63.
    Bruning K, Selder F. From hospital to home healthcare: the need for medication reconciliation. Home Heal Nurse. 2011;29(2):81–90.CrossRefGoogle Scholar
  64. 64.
    Wekre LJ, Spigset O, Sletvold O, Sund JK, Grimsmo A. Multidose drug dispensing and discrepancies between medication records. Qual Saf Heal Care. 2010;19(5):e42.Google Scholar
  65. 65.
    Atkinson WL, Frey D. Integration of a medication management model into outcome-based quality improvement: a pilot program in a rural propriety home healthcare agency. Home Heal Care Serv Q. 2005;24(1–2):29–45.CrossRefGoogle Scholar
  66. 66.
    Blais R, Sears NA, Doran D, Baker GR, Macdonald M, Mitchell L, et al. Assessing adverse events among home care clients in three Canadian provinces using chart review. BMJ Qual Saf. 2013;22(12):989–97.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000;55(10):M554–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Clinical Pharmacy & Epidemiology, Department of Pharmaceutical SciencesUniversity of BaselBaselSwitzerland
  2. 2.Hospital PharmacyUniversity Hospital of BaselBaselSwitzerland
  3. 3.School of PharmacyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations